Systematic Review
Published on 29 Nov 2022
Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis
in Thoracic Oncology
![Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis](https://www.frontiersin.org/files/myhome article library/1001503/1001503_Thumb_400.jpg)
- 3,224 views
- 2 citations